ACM
PLRX icon

Aquatic Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Aquatic Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,596
Closed -$73.7K – 1559
2024
Q4 		$73.7K Buy
5,596
+5,196
+1,299% +$70.9K ﹤0.01% 1117
2024
Q3 		$4.48K Sell
400
-3,600
-90% -$45K ﹤0.01% 1099
2024
Q2 		$43K Sell
4,000
-1,900
-32% -$24.5K ﹤0.01% 1035
2024
Q1 		$87.9K Buy
5,900
+3,400
+136% +$56.1K ﹤0.01% 942
2023
Q4 		$45K Sell
2,500
-2,800
-53% -$42.6K ﹤0.01% 1134
2023
Q3 		$92K Sell
5,300
-12,500
-70% -$217K ﹤0.01% 831
2023
Q2 		$323K Buy
+17,800
New +$421K 0.02% 547
2023
Q1 		– Sell
-10,200
Closed -$196K – 1652
2022
Q4 		$196K Buy
+10,200
New +$213K 0.01% 738

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Aquatic Capital Management's PLRX Position: Q1 2025 in Review

Aquatic Capital Management sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 5,596 shares — an estimated $73.7K sold.

Aquatic Capital Management first reported a position in PLRX in Q4 2022 and held it in 8 quarters. The position peaked at $323K in Q2 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Aquatic Capital Management reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 5,596 Pliant Therapeutics shares in Q1 2025, an estimated $73.7K.
  • Aquatic Capital Management first reported a position in Pliant Therapeutics in Q4 2022 and held it in 8 quarters.
  • Aquatic Capital Management's Pliant Therapeutics position peaked at $323K in Q2 2023.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.